» Articles » PMID: 36200070

Upregulation of Circ_0008812 and Circ_0001583 Predicts Poor Prognosis and Promotes Breast Cancer Proliferation

Overview
Specialty Biology
Date 2022 Oct 6
PMID 36200070
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence suggests that circular RNAs (circRNAs) are highly correlated with tumor progression and pathogenesis in breast cancer. Whereas, their regulatory roles and corresponding mechanisms in breast cancer are still not exhaustive. Thus, we intended to establish circRNA-mediated competive endogenous RNA (ceRNA) network to uncover the possible roles and clinical implications of circRNAs in breast cancer. Microarray and RNA-sequencing (RNA-seq) data were download from GEO and TCGA database to screen for differentially expressed RNAs (DEcircRNAs, DEmiRNAs, DEmRNAs) in breast cancer. By implementing online databases, we established ceRNA networks, performed gene set enrichment analysis, constructed protein-protein interaction (PPI) networks, and assessed the expression levels and prognostic significance of hub genes. Subsequently, we explored the functions of prognosis-related genes and constructed gene-drug interaction networks. Finally, the functional roles of DEcircRNAs in breast cancer were revealed MTT and colony formation assay. Based on the identified 8 DEcircRNAs, 25 miRNAs and 216 mRNAs, a ceRNA regulatory network was established. Further analysis revealed that prominent enrichments were transcription factor binding, transforming growth factor-beta (TGF-β) and Apelin signaling pathway etc. PPI network and survival curves analysis showed that elevated levels of hub genes (RACGAP1 and KPNA2) were associated with poorer prognosis. They were found to be positively relevant to cell cycle and proliferation. Then a prognostic sub-network of ceRNA was constructed, consisting of 2 circRNAs, 4 miRNAs and 2 mRNAs. The gene-drug interaction network showed that numerous drugs could regulate the expression of these two prognosis-related genes. Functional experiments showed that depletion of circ_0008812 and circ_0001583 could significantly inhibit the proliferation of MCF-7 cells. Our study constructed 4 prognostic regulatory axes that are significantly correlated with tumor prognosis in breast cancer patients, and uncover the roles of circ_0008812 and circ_0001583 in breast cancer, providing a new perspective into the molecular mechanisms of breast cancer pathogenesis.

Citing Articles

CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis.

Bhat A, Gupta G, Dahiya R, Thapa R, Gahtori A, Shahwan M Noncoding RNA Res. 2024; 9(2):277-287.

PMID: 38505309 PMC: 10945146. DOI: 10.1016/j.ncrna.2024.01.013.


Identification of circRNA-miRNA-mRNA network in luminal breast cancers by integrated analysis of microarray datasets.

Huang Y, Qian M, Chu J, Chen L, Jian W, Wang G Front Mol Biosci. 2023; 10:1162259.

PMID: 37187897 PMC: 10175596. DOI: 10.3389/fmolb.2023.1162259.

References
1.
Sheng H, Pan H, Yao M, Xu L, Lu J, Liu B . Integrated Analysis of Circular RNA-Associated ceRNA Network Reveals Potential circRNA Biomarkers in Human Breast Cancer. Comput Math Methods Med. 2021; 2021:1732176. PMC: 8712159. DOI: 10.1155/2021/1732176. View

2.
Qu S, Liu Z, Yang X, Zhou J, Yu H, Zhang R . The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2017; 414:301-309. DOI: 10.1016/j.canlet.2017.11.022. View

3.
Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

4.
Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

5.
Flores-Perez A, Marchat L, Rodriguez-Cuevas S, Bautista V, Fuentes-Mera L, Romero-Zamora D . Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells. BMC Cancer. 2016; 16:379. PMC: 4932667. DOI: 10.1186/s12885-016-2470-3. View